TKG Huchems Valuation Multiples
Discover TKG Huchems' revenue and EBITDA valuation multiples and M&A history.
TKG Huchems Overview
About TKG Huchems
TKG Huchems Corp is a Korea based company, which operates as a chemical product manufacturer. It provides materials of fine chemical such as Nitric acid, DNT, MNB and Ammonium Nitrate. The business activity of the group is carried out through two divisions namely Chemical and Environment-Friendly division. The Chemical division provides fine chemicals and basic chemicals and the Environment-Friendly division includes a clean development mechanism (CDM) project and urea solution.
Founded
2002
HQ
Employees
N/A
Website
Financials (LTM)
EV
$242M
Valuation Multiples
Start free trial
TKG Huchems Financials
TKG Huchems reported last 12-month revenue of $828M and EBITDA of $87M.
In the same LTM period, TKG Huchems generated $90M in gross profit, $87M in EBITDA, and $45M in net income.
TKG Huchems P&L
In the most recent fiscal year, TKG Huchems reported revenue of $777M and EBITDA of $91M.
TKG Huchems is profitable as of last fiscal year, with gross margin of 10%, EBITDA margin of 12%, and net margin of 5%.
Financial data powered by Morningstar, Inc.
TKG Huchems Stock Performance
TKG Huchems has current market cap of $394M, and enterprise value of $242M.
TKG Huchems' stock price is $10.28.
TKG Huchems has an EPS (earnings per share) of $1.06.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $242M | $394M | -0.1% | - | - | - | $1.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialTKG Huchems Valuation Multiples
TKG Huchems trades at 0.3x EV/Revenue multiple, and 2.8x EV/EBITDA.
TKG Huchems Financial Valuation Multiples
As of July 9, 2026, TKG Huchems has market cap of $394M and EV of $242M.
TKG Huchems has a P/E ratio of 8.8x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified TKG Huchems Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
TKG Huchems Margins & Growth Rates
TKG Huchems grew revenue by 13% and EBITDA by 0% in the last fiscal year.
In the most recent fiscal year, TKG Huchems reported gross margin of 10%, EBITDA margin of 12%, and net margin of 5%.
TKG Huchems Margins
TKG Huchems Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
TKG Huchems Operational KPIs
TKG Huchems' Rule of 40 is 28% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
TKG Huchems' Rule of X is 55% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
TKG Huchems Competitors
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
This data is available for Pro users. Sign up to see all TKG Huchems competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by TKG Huchems
TKG Huchems has acquired 1 company to date.
Last acquisition by TKG Huchems was on June 25th 2026. TKG Huchems acquired AprilBio for $103M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by TKG Huchems
| Description | AprilBio Co Ltd is a bio company is developing biologis. It owns long acting protein medicine platform technology utilizing human FAB antobody parts that makes unusual combination to serum akbumin and EX 12 helper phase antibody library technology. |
| HQ Country |  |
| HQ City | Chuncheon |
| Deal Date | 25 Jun 2026 |
| Valuation | $103M |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all TKG Huchems acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout TKG Huchems
| When was TKG Huchems founded? | TKG Huchems was founded in 2002. |
| Where is TKG Huchems headquartered? | TKG Huchems is headquartered in South Korea. |
| Is TKG Huchems publicly listed? | Yes, TKG Huchems is a public company listed on Korea Exchange. |
| What is the stock symbol of TKG Huchems? | TKG Huchems trades under 069260 ticker. |
| When did TKG Huchems go public? | TKG Huchems went public in 2002. |
| Who are competitors of TKG Huchems? | TKG Huchems main competitors include |
| What is the current market cap of TKG Huchems? | TKG Huchems' current market cap is $394M. |
| What is the current revenue of TKG Huchems? | TKG Huchems' last 12 months revenue is $828M. |
| What is the current revenue growth of TKG Huchems? | TKG Huchems revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of TKG Huchems? | Current revenue multiple of TKG Huchems is 0.3x. |
| What is the current EBITDA of TKG Huchems? | TKG Huchems' last 12 months EBITDA is $87M. |
| What is TKG Huchems' EBITDA margin? | TKG Huchems' last 12 months EBITDA margin is 11%. |
| What is the current EV/EBITDA multiple of TKG Huchems? | Current EBITDA multiple of TKG Huchems is 2.8x. |
| What is the current FCF of TKG Huchems? | TKG Huchems' last 12 months FCF is $67M. |
| What is TKG Huchems' FCF margin? | TKG Huchems' last 12 months FCF margin is 8%. |
| What is the current EV/FCF multiple of TKG Huchems? | Current FCF multiple of TKG Huchems is 3.6x. |
| How many companies TKG Huchems has acquired to date? | As of July 2026, TKG Huchems has acquired 1 company. |
| What was the largest acquisition by TKG Huchems? | $103M acquisition of AprilBio on 25th June 2026 was the largest M&A TKG Huchems has done to date. |
| What companies TKG Huchems acquired? | TKG Huchems acquired AprilBio. |
| In how many companies TKG Huchems has invested to date? | TKG Huchems hasn't invested in any companies yet (or none have been disclosed publicly). |
Lists including TKG Huchems
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.